Skip to Content


Stay informed on the latest news and updates from NKILT.

NKILT Therapeutics Announces New Scientific Advisory Board Appointments

HOUSTON, TX – JUNE 6, 2023 – (PRNewswire) – NKILT Therapeutics, a new biotech company committed to the development of novel natural killer (NK) cell therapies, announced today the appointment to their Scientific Advisory Board (SAB) of Saar Gill, MD, PhD, as Chairman and Maksim Mamonkin, PhD, as scientific advisor.

Read full press release


Check back soon to see what’s new. In the meantime, visit our LinkedIn page for updates.

View past events